Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Features

Top News in Endovascular Therapy: 2018

L.A. McKeown

December 28, 2018

News Conference News VIVA 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

L.A. McKeown

November 09, 2018

News Daily News

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

L.A. McKeown

October 18, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News SCAI 2018

FLARE Trial: Novel Device Safe and Efficacious for Catheter-Derived Mechanical Thrombectomy in PE

L.A. McKeown

April 27, 2018

News Conference News ACC 2018

COMPASS Approach Helps With Leg Complications in Patients With PAD

Todd Neale

March 12, 2018

News Daily News

Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II

Michael O'Riordan

February 21, 2018

News Industry News

New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment

January 29, 2018

News Daily News

Shifts in Stroke Score Over Time Help Hone Risk Prediction

Todd Neale

January 10, 2018

News Daily News

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

L.A. McKeown

January 02, 2018

Advertisement

Top News in Endovascular Therapy: 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

FLARE Trial: Novel Device Safe and Efficacious for Catheter-Derived Mechanical Thrombectomy in PE

COMPASS Approach Helps With Leg Complications in Patients With PAD

Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II

New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment

Shifts in Stroke Score Over Time Help Hone Risk Prediction

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content